Business Name: |
Priority Pharmaceuticals Inc |
Contact Person: |
David C Zeiger |
Address: |
4040 Sorrento Valley Boulevard, San Diego, California 92121 |
Phone Number: |
(858) 404-9250 |
Website Address: |
prioritypharm.com |
Annual Revenue (USD): |
$5.000.000 to $9.999.999 |
Founding Year: |
1978 |
Location Type: |
Headquarters |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Wholesale Pharmaceutical Products |
SIC Code: |
5122 |
NAICS Code: |
424210 |
Share This Business: |
|
Related Businesses: |
Dithera Inc - San Diego, CA 92121 Zensung USA Inc - San Diego, CA 92121 Priority Pharmaceuticals - San Diego, CA 92121 Southern California Compounding Pharmacy - San Diego, CA 92121 Therinject - San Diego, CA 92121 Signal Pharmaceuticals LLC - San Diego, CA 92121 Polynoma - San Diego, CA 92121 Cardinal Health - San Diego, CA 92121 Sundia Meditech Inc - San Diego, CA 92121 Salameh Tamer - San Diego, CA 92121 Celgene Corporation - San Diego, CA 92121 Fgx Pharmaceuticals - San Diego, CA 92121 Irisys Inc - San Diego, CA 92121 Epicyte Pharmaceuticals Inc - San Diego, CA 92121 Omnicare of San Diego - San Diego, CA 92121 Skye Pharma Inc - San Diego, CA 92121 |
The company Priority Pharmaceuticals Inc provides B2B services in the form of Wholesale Pharmaceutical Products from its headquarters in California.
1 to 4 employees work for Priority Pharmaceuticals Inc, and the business now earns $5.000.000 to $9.999.999 per annum.
Priority Pharmaceuticals Inc was launched in 1978 and is classified under SIC code and category 5122 , and NAICS number and grouping 424210 .
To contact Priority Pharmaceuticals Inc, please call David C Zeiger with the phone number (858) 404-9250 or visit its headquarters at 4040 Sorrento Valley Boulevard in San Diego, California 92121.
The location of the headquarters can also be found using the coordinates 32.903735,-117.218556.
Read more details about this business on the webpage prioritypharm.com or follow the company’s social media accounts, on Twitter and on Facebook.